Abstract

Our recent study in individuals with major depressive disorder (MDD) elicited six prioritized attributes in selecting treatments to manage their condition: Treatment Mode, Time to Treatment Effect, MDD Relief, Quality of Work, Interaction with Others, and Affordability. This study aims to identify whether previous cost-effectiveness analyses (CEAs) in MDD addressed these patient-important attributes, whether patients were engaged in the modeling process, and whether patient preferences for treatment attributes were incorporated into the economic evaluations.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call